A 3.35x book multiple sits well above every name in the supplied peer table, from 0.87x at Regional Management to 2.40x at World Acceptance, which suggests investors are paying for a structurally higher return on equity rather than a cheaper balance sheet; if quarterly ROE of 7.0% annualizes near 28%, the premium is arithmetically defensible, but only if that return level survives the next credit cycle. The steep discount between trailing and forward P/E appears to embed continued provision relief rather than revenue acceleration, since roughly two-thirds of recent operating income improvement has come from lower reserve builds, so the multiple is sensitive to any renewed reserve build. One data caveat warrants attention: the P/B column in the supplied ratio table rises steadily from 41.07 to 59.34, a pattern that tracks a price-like level rather than a book multiple, so the 3.35x headline figure should be verified against reported book value before it anchors conclusions.

The DuPont bridge here is unusual for a depository: with net interest income near zero in eight of the last ten quarters, essentially all of the 1.4% quarterly ROA is generated by fee and finance-charge income, so profitability quality hinges on origination pricing and cost per funded loan rather than spread income. The second lever is leverage, which rose as total assets grew about 60% against roughly 45% equity growth, meaning part of the ROE climb from 3.7% to 7.0% reflects a thinner equity base rather than improved operating efficiency. The third and least durable component is the reserve trajectory, since the $85.1M release in 2026Q1 and the decline in provisions from $428.9M to $291.3M flatter net income without any change in origination economics, so investors should test how much of the current ROE persists at a flat provision-to-revenue ratio.

The NIM series appears unusable for trend analysis: with net interest income reported at or below zero in most quarters and a lone $769.3M print in 2026Q1, the spread metric reflects presentation choices rather than an economic funding advantage, so it should be treated as data unavailable rather than as a margin signal. The efficiency ratio tells a similar story, swinging from 24.6% in 2024Q3 to 84.0% in 2026Q1 alongside fee income percentages that jump from 100.0% to 1.5% and back to 111.4%, which suggests the denominator is being reclassified between quarters. The cleaner operating read is the 23.5% operating margin achieved on 18.6% revenue growth, which indicates genuine cost scaling, and investors should monitor that figure rather than the efficiency ratio until the revenue classification is reconciled.

CET1, Tier 1, and total capital ratios are not disclosed in the supplied data, which is expected for a non-bank specialty lender outside bank holding company rules, so regulatory minimum tests cannot be run and equity-to-assets of 0.20 alongside a reported debt-to-equity of 3.41 are the available proxies. Interpreted that way, the balance sheet still carries a meaningful equity buffer versus leveraged peers such as Regional Management at 4.65 D/E, but the direction of travel matters: capital is being returned faster than it is being retained while cash sits below 2% of assets. The discretionary nature of the repurchases, which ranged from $19.8M in 2026Q2 to $85.5M in 2025Q1, suggests buybacks could pause without warning if credit conditions or wholesale funding availability tighten, and investors should watch whether the 0.20 equity ratio holds as a floor through the next origination push.

The valuation gap versus Regional Management and PRA Group appears structural rather than cyclical: Enova's digital-only underwriting and absence of branch overhead support structurally lower operating costs than branch-based lenders like OneMain and World Acceptance, which the market seems to be capitalizing at 3.35x book. The earnings multiple comparison is less clean, since Enova's 14.68x trailing P/E sits between Regional Management's 7.31x and World Acceptance's 24.33x, suggesting the market does not uniformly reward or punish non-prime lenders and instead differentiates on leverage and reserve discipline; Enova's D/E of 3.41 falls between Regional Management's 4.65 and QCR Holdings' 0.56, placing it mid-pack on funding risk. PRA Group's negative ROE and 0.72x book are not comparable at the earnings level and should be excluded from multiple averaging, leaving World Acceptance as the most relevant upper-bound valuation reference.